Additionally, human CD8+ CAR-Tregs have been shown to enhance the suppression of human skin rejection and GVHD in NSG mice196, suggesting a potential benefit of CD8+ CAR-Tregs in transplantation. Here, CD8A is linked to graft versus host disease.